På foranledning af The Mule…. din mening ?

By On 19. September 2012 · Leave a Comment · In BioPorto

About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂

Related posts:

  1. 1st Class versus Second Rate… User Ann (again)   – I’m having a hard time...
  2. Thea Olesen in Medwatch RSVP (répondez, s’il vous plaît) in Medwatch – Thea Olesen....
  3. The recent development in Triage/Trauma NGAL-patent The USPTO’s Christine Foster ist still not happy with the...
  4. BioPorto vs Phadia … BioPorto won 2-0 Today the judges of Sø & Handelsretten gave their verdict...
  5. NGAL BioPorto and Phadia in Medwatch.dk NGAL – For the benefit of our esteemed readers from...
 

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.